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OBJECTIVES: Normal endothelial cells respond to shear stress by elongating and aligning in the direction of fluid
flow. Hyperglycemia impairs this response and contributes to microvascular complications, which result in
deleterious effects to the endothelium. This work aimed to evaluate cheek pouch microvessel morphological
characteristics, reactivity, permeability, and expression of cytoskeleton and extracellular matrix components in
hamsters after the induction of diabetes with streptozotocin.
METHODS: Syrian golden hamsters (90–130 g) were injected with streptozotocin (50 mg/kg, i.p.) or vehicle either 6
(the diabetes mellitus 6 group) or 15 (the diabetes mellitus 15 group) days before the experiment. Vascular
dimensions and density per area of vessels were determined by morphometric and stereological measurements.
Changes in blood flow were measured in response to acetylcholine, and plasma extravasation was measured by the
number of leakage sites. Actin, talin, a-smooth muscle actin, vimentin, type IV collagen, and laminin were detected
by immunohistochemistry and assessed through a semiquantitative scoring system.
RESULTS: There were no major alterations in the lumen, wall diameters, or densities of the examined vessels.
Likewise, vascular reactivity and permeability were not altered by diabetes. The arterioles demonstrated increased
immunoreactivity to vimentin and laminin in the diabetes mellitus 6 and diabetes mellitus 15 groups.
DISCUSSION: Antibodies against laminin and vimentin inhibit branching morphogenesis in vitro. Therefore, laminin
and vimentin participating in the structure of the focal adhesion may play a role in angiogenesis.
CONCLUSIONS: Our results indicated the existence of changes related to cell–matrix interactions, which may
contribute to the pathological remodeling that was already underway one week after induction of experimental
diabetes.
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INTRODUCTION
The microcirculation represents a unique environment
that acts as the site of gas and nutrient exchange between
blood and tissues.
1 Microvessel networks are often idealized
as a set of vessels of different categories that are connected
in a series with the parallel vessels in each category
exhibiting identical properties.
1 In reality, however, the
structures of microvessel networks are highly heteroge-
neous. This heterogeneity has important effects on the
functional behavior of the microcirculation.
2 Consequently,
the physiology, biochemistry, and pharmacology vary
according to the portion of the network that is studied
and the location within different tissues.
1
Diabetes mellitus is caused by physical or functional loss
of beta-cell mass, which results in hyperglycemia. In turn,
hyperglycemia contributes to microvascular complications,
which result in deleterious effects on the endothelium.
Endothelial and smooth muscle cells are largely responsible
for regulating vascular tone and permeability, and they
make up the subendothelial matrix. Endothelial dysfunction
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1961is regarded as an important factor in the pathogenesis of
microangiopathy.
3
Numerous hyperglycemia-related mechanisms have been
hypothesized to mediate micro- and macrovascular compli-
cations. These mechanisms include the polyol and hexo-
samine pathways, protein kinase C (PKC) activation,
generation of reactive oxygen species, poly(ADP-ribose)
polymerase (PARP) activation, and the accumulation of
advanced glycoxidation or glycation end-products (AGEs).
4
Microvascular deterioration in diabetes has been asso-
ciated with increased blood flow, venular dilation, basement
membrane thickening, increased exudation of plasma
proteins, decreased density of microvessels, and decreased
oxygen supply to the tissues.
5
Several investigators have described an increase in
microvascular permeability
6 and changes in endothelium-
dependent relaxation
7 in streptozotocin (STZ)-induced
diabetic animals during the prediabetic period (six–eight
weeks). These changes could be due to increased intravas-
cular pressure, which occurs as a result of the increased
shear stress on the vascular luminal surface,
8 and the
accumulation of extracellular matrix and cytoskeleton
proteins glycated by AGEs.
9 The regulation of these
processes occurs via the mechanically stimulated release
of potent, shear-responsive, endothelial-derived factors,
such as nitrovasodilators, prostaglandins, lipoxygenases,
hyperpolarizing factors, growth factors.
10
In contrast to vessel changes observed during acute
vasoregulation, sustained changes in the local hemody-
namics promote the adaptive structural remodeling of the
arterial wall through endothelium-dependent regulation of
gene and protein expression.
11 Moreover, morphologic
alteration of arterioles, capillaries, and venules has been
demonstrated after chronic hyperglycemia in diabetic
human subjects, rats, and mice.
12
Prolonged hyperglycemic states result in the generation of
reactive oxygen species, which leads to morphological
changes in response to endothelial dysfunction.
13 These
morphological changes ultimately require the dynamic
cytoskeleton and its interaction with the extracellular matrix
(ECM).
14
Most previous analyses of microvessels in the hamster
cheek pouch model and other animal models have been
performed after a period of two weeks from the develop-
ment of diabetes.
5,6 Early alterations (first two weeks) in the
microvasculature that may contribute to the onset and
progression of type 1 diabetes, however, remain elusive.
Thus, an integrated analysis of the structural and physio-
logical parameters of the microcirculation during the first
two weeks of diabetes development is necessary.
The main purpose of this work was to qualitatively
describe the structural alterations that occur in microvessels
and in the cytoskeleton and ECM components during the
early stage of diabetes mellitus development. In addition,
we wanted to study the sensitivity of the microvascular
membrane to histamine and the endothelium-dependent
relaxation induced by acetylcholine.
MATERIALS AND METHODS
Animals and Induction of Diabetes Mellitus
The study protocol was approved by the Ethics
Committee for Experimental Animals, no. CEA 004/2009,
of the State University of Rio de Janeiro, Brazil. All
procedures were carried out in accordance with the
conventional guidelines for experimentation with animals.
Twenty-four male Syrian golden hamsters (Mesocricetus
auratus), seven to ten weeks old and weighing 90-130 g,
were maintained in separate cages under controlled
temperature and humidity and a 12/12 h light/dark cycle.
Animals had free access to food and water.
Syrian golden hamsters were randomly divided into a
control group (CG) and a diabetic group. Experimental type
1 diabetes mellitus was induced by intraperitoneal (i.p.)
injections of STZ (50 mg/kg body weight/day, Sigma
Chemical Co., St. Louis, MO, USA) dissolved in 50 mmol/
l sodium citrate buffer (pH 4.5) for three consecutive days (a
total dose of 150 mg/kg) at intervals of 24 h. Hamsters in
the CG (n=8) received sodium citrate buffer alone. Diabetic
animals were further divided according to the duration after
STZ administration: 6 days (n=8; DM6) or 15 days (n=8;
DM15) of diabetes development. Before the STZ injection
and at 1 h, 24 h, and 3, 6, and 15 days after the last injection,
postprandial blood glucose and body mass were measured
to confirm diabetes ($210 mg/dl). Three days after the last
STZ injection, the diabetic condition was confirmed. Only
animals showing weight loss (due to uncontrolled diabetes)
and severe hyperglycemia were considered for the analyses.
Intravital Microscopy of the Hamster Cheek Pouch
Hamsters from each group were prepared for intravital
microscopy according to the methods described in Svensjo ¨
(1999)
6 at 6 or 15 days after the STZ treatment. Animals were
anesthetized with an injection of sodium pentobarbital
(60 mg/ml, i.p.) supplemented with i.p. dose of a-chloralose
(100 mg/kg) through a femoral vein catheter, and body
temperature was kept at 36.5˚C. To facilitate spontaneous
breathing, a tracheostomy was performed. The right femoral
vein was cannulated for the administration of fluorescein-
dextran (FITC–dextran, MW 150,000, TdB Consultancy,
Uppsala, Sweden), which was used to measure the restric-
tiveness of the microvascular membrane permeability.
Alterations in the postcapillary venular permeability were
measured using semiquantitative methods by counting sites
with extravasation of fluorescent plasma (leaky sites=leaks)
at 0, 2, and 5 min after the topical application of histamine
(10
-6 mol). To determine the vascular reactivity, the luminal
diameter of selected arterioles and venules (40-90 mm) was
measured both before and 10 min after the microapplication
of acetylcholine (10
-4 mol, micropipette 10-12 mm and
constant volume of 200 ml/min). Microvessels were ana-
lyzed using a millimetric ocular lens of a light microscope
and observed with a computer-assisted method on analog–
digital-converted, video-recorded images. To avoid bias due
to single-operator measurements, two independent blinded
operators measured vessel diameters.
Morphometric and Stereologic Analysis
To reduce measurement errors, intimal (IL) and media
layers (ML) were analyzed by different techniques. To
determine the thickness of the IL, the cheek pouch was fixed
in 2.5% glutaraldehyde and 2.0% paraformaldehyde in
0.15 M cacodylate buffer (pH 7.2) for 2 h. The IL was then
postfixed in 1% osmium tetroxide, stained in 2% uranyl
acetate, dehydrated in acetone, and embedded in epoxy
resin (Epon-812, SEM, Hatfield, PA, USA). Thin sections
(1 mm thick) were stained with 0.25% toluidine blue in 1%
acetic acid (Vetec, Brazil) and observed under a light
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1962microscope (Axiophot, Carl Zeiss, Germany). Media layer
thickness was determined using light microscopy with
immunolabeling for a-smooth muscle actin (a-SMA). For
details on immunohistochemistry, please see section
‘‘Immunohistochemistry Assay’’.
The digital images of 20 vessels for each hamster (TIFF
format, 36-bit color, 1,280 X 1,024 pixels) were acquired
using a 100X oil-immersion objective lens and manually
quantified with the Image-Pro Plus 4.5 program (Image Pro
Plus 4.5, Media Cybernetics, Bethesda USA). This sample
size was based on previous studies and was designed to
avoid biases related to inter-animal variability.
15,16
Vascular dimensions were measured taking into account
three parameters: lumen diameter, wall thickness and wall/
lumen ratio. We obtained four measurements of IL and ML
thickening(i.e., at0˚C, 90˚C,180˚C and270˚C). The luminal area
was measured from the internal circumferential line, and the
lumen diameter was calculated from the area. The percentage
of thickening was measured by the lumen/wall ratio.
17 It is
important to highlight that the lumen diameter, wall thickness
and lumen/wall ratio measurements in hamsters were
obtained from a previous work,
5 and the measures from the
previous study were used as a pattern for the species.
The volume density was analyzed by stereology using a
test system composed of 36 test points (PT)
15 and estimated
by the following equation: Vv [structure] = Pp [structure]/
Pt, where Pp is the number of points that hit the structure,
and Pt is the total number of test points inside the test
system. The density per area was estimated for vessels
(arterioles or venules) with the following equation:
QA[structure] = N[structure]/AT (1 mm
2), where N is the
number of profiles counted in the test area (i.e., the frame
AT), considering the forbidden line and its extensions.
15
Immunohistochemistry Assay
Paraffin sections of cheek pouches were deparaffinized,
rehydrated, and incubated (10 min) with 0.3% H2O2 in
methanol to block endogenous peroxidase. Nonspecific
protein binding was blocked by incubation with 1% bovine
serum albumin diluted in phosphate-buffered saline (PBS/
BSA). Antigen retrieval for ECM components was per-
formed with trypsin (3%) diluted in distilled water for
10 min at 37˚C and the sections were incubated with the
primary antibody diluted 15100 with 1% PBS/BSA over-
night (4˚C, in a humid atmosphere). Cytoskeleton protein
sections were incubated in 10 mM sodium citrate buffer
(pH 6.0, Antigen Unmasking Solution, H-3300; Vector
Laboratories, CA, USA) at 98˚C for 20 min and subsequently
incubated with the primary antibody diluted 1525. After
washing with PBS, slides were incubated with reagent from
the Labeled Streptavidin-Biotin System (LSAB) immunohis-
tochemical kit (LSAB-kit, Dako, Carpinteria, CA). Sections
were then counterstained with hematoxylin and mounted
using an aqueous mounting medium. Control sections were
processed after the omission of the primary antibody.
Immunohistochemistry staining was evaluated based on a
semiquantitative scoring system: score 0, no label; score 1,
poor label; score 2, medium label; score 3, strong label.
16
Data Analysis
All data are presented as the mean ¡ the standard error
of the mean (SEM) and tested with one-way ANOVA
followed by Tukey’s test, using the GraphPad Prism
program (5.0 version, GraphPad Software San Diego,
USA). In all cases, p,0.05 was considered statistically
significant.
RESULTS
Effects of STZ-Induced Diabetes on Body Weight
and Morphofunctional Parameters
As expected, glycemia was extremely high in the
hamsters in the diabetic groups. The hamsters were only
persistently hyperglycemic after the third day after STZ
administration. Compared with the CG, glycemia was
increased two-fold in diabetic hamsters 6 days (DM6) after
STZ administration and increased almost three-fold in
diabetic hamsters 15 days (DM15) after the induction of
diabetes (p,0.001 for the CG vs. DM6 and DM15). The
degree of glycemia was also different between DM6 and
DM15 (p,0.05, Figure 1A). In addition, diabetic hamsters
suffered a significant reduction in body weight. The control
group showed a weight gain of approximately 5% from day
0 to day 6, whereas the DM6 hamsters displayed a loss in
body weight of around 15% for the same time period
(p,0.05 for the CG vs. DM6). DM15 hamsters lost 20%
compared with the control (p,0.001 for the control group
vs. DM15) (Figure 1B).
There were significant differences (p,0.05) in the micro-
vascular permeabilities of both the diabetic subgroups
(105¡3 and 112¡8 leakage sites/cm
2 for the DM6 and
DM15 groups, respectively) compared with the control
group (158¡13 leakage sites/cm
2) 2 min after the end of the
topical application of histamine. The peak vascular
response, however, usually occurred at 3 to 5 min after
the application and dissipated within 10 or 20 min (data not
shown). Responses were not significantly different between
any two groups at 5 min (p.0.05, Figure 1C). For acetylcho-
line, there were no significant differences between the
diabetic and control hamsters in any determination for any
vessel tested (arterioles or venules) (p.0.05 for comparison
between groups, Figure 1D).
Table 1 shows that no significant differences between
groups were observed for morphometric or stereological
parameters. Microvessel density per cheek pouch area (QA)
and volume density (Vv) were estimated to determine the
amount of cheek pouch vascularization in age-matched
control and diabetic hamsters. For both parameters, the
number of venules was two times greater than the number
of arterioles, but no significant difference between groups
was observed in any analysis (p.0.05).
Immunohistochemistry Score
Actin expression increased in arterioles of the DM6 hamsters
compared with the CG. DM15 hamsters do not alter actin
expression compared with the CT but showed decrease
compared with the DM6 hamsters (CG, score 1; DM6, score
2; DM15, score 1). Actin immunoreactivity was seen in all
endothelial and smooth muscle cells (data not shown). There is
no difference in actin or talin immunostaining in venules
between the groups. The a-SMA immunostaining in arterioles
do not change between the groups. In arterioles, talin
immunostaining showed an increase in DM6 hamsters when
compared to control hamsters. Talin-positive vessels decreased
in DM15 hamsters when compared to DM6 hamsters and there
is no different relationship with the control group (CG, score 1;
DM6, score 3; DM15, score 1). Immunoreactivity for talin was
positive in endothelial cells and smooth muscle cells (data not
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1963shown). a-SMA expression in venules was increased in the
DM6 hamsters compared with the control and the DM15
hamsters (CG, score 1; DM6, score 3; DM15, score 1). Vimentin-
positive arterioles and venules increased in DM6 and DM15
hamsters when compared to control hamsters (CG, score 1;
D M 6 ,s c o r e2 ;D M 1 5 ,s c o r e2 ) .I nt h eC G ,t h ea n t i - v i m e n t i n
antibody only reacted with some endothelial cells, but
immunoreactivity was also apparent in smooth muscle cells
in both of the diabetic groups. Furthermore, a greater number
of cells stained positively for vimentin in the DM6 and DM15
groups compared with the CG (Figure 2).
The expression of laminin was more apparent in hamsters
in the first week after STZ induction of diabetes than in the
control hamsters. Laminin labeling was maintained for 15
Figure 1 - The mean ¡ the standard error of the mean (SEM) for glycemia, body weight, and microvascular responses to histamine and
acetylcholine in age-matched controls and hamsters at 6 (DM6) and 15 days (DM15) after the induction of diabetes with streptozotocin
(STZ, 50 mg/kg). Statistical significance was determined using one-way ANOVA followed by Tukey’s post-hoc analysis. A. Glycemia (mg/
dl): p,0.001 for the control group vs. both DM6 and DM15, and p,0.05 for the DM6 group compared with the DM15 group. B. Body
weight (g): p,0.05 for the control group vs. the DM6 group, p,0.001 for the control group vs. the DM15 group, and p,0.05 for the
DM6 group vs. the DM15 group. C. Microvascular responses (number of dextran 150kDa leakage sites per cm
2) to histamine (10
-6 M).
There were no significant differences between the groups (p.0.05). D. Responses (as percent increase in lumen diameter) of arterioles
and venules to topical application of acetylcholine. There were no significant differences between the groups (p.0.05).
Table 1 - Morphological and stereological measurements of microcirculatory vessels of age-matched control and
diabetic hamsters.
Measurements/Groups/Vessels Control 6 days of diabetes 15 days of diabetes
Arterioles Venules Arterioles Venules Arterioles Venules
Thickness of the intimal and media layers (mm)
Lumen diameter 31¡2.7 40¡33 3 ¡1.2 42¡2.4 25¡2.5 35¡3.1
Wall thickness 5.7¡0.7 3.6¡0.6 5.4¡0.9 2.7¡0.4 3.8¡0.4 2.4¡0.2
Wall/lumen ratio 0.2 0 0.1 0 0.2 0 0.1 0 0.2 0 0.1 0
Thickness of the media layer (mm)
Lumen diameter 38¡3.7 41¡2.4 30¡3.8 32¡2.1 28¡7.4 39¡5.4
Wall thickness 5.3¡0.3 2.6¡0.2 5.4¡0.2 2.5¡0.1 5¡0.8 2.4¡0.1
Wall/lumen ratio 0.1 0 0.1 0 0.2 0 0.1 0 0.2 0 0.1 0
Density per cheek pouch area (QA) (mm
2.10
2)
QA 3.2¡0.7 8.8¡1.3 3.2¡0.5 7.2¡1 3.5¡0.7 9.7¡1
Volume density (Vv) (%)
Vv 5.5¡1.3 11¡1.5 5.3¡1.1 11¡1.6 5.2¡1.4 10¡1.9
Values are the mean¡the standard error of the mean. p-values are not significant for any data measured.
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1964days in the diabetic group for both vessel types (arterioles
and venules). Figure 3 shows that the IL was immunor-
eactive for laminin in the CG; however, higher levels of
laminin expression were observed in all layers of the
vascular wall in the diabetic groups (CG, score 1; DM6,
score 2; DM15, score 2). There was no difference in collagen
IV staining between the two diabetic groups and the control
hamsters. Table 2 shows the distribution scores for
cytoskeleton ECM proteins.
DISCUSSION
Hyperglycemia exerts deleterious effects on the endothe-
lium, which is the regulator of the vascular wall.
3
Abnormalities in the modulatory roles played by the
endothelium and/or smooth muscle may be critical and can
actasinitiatingfactorsinthedevelopmentofdiabeticvascular
disease.
18 We observed unaltered endothelium-dependent
vasorelaxation at an early stage in STZ-induced diabetes. In
our work, the vasorelaxation derived from the endothelium
remained unchanged, at least until the 15
th day of diabetes
development. Our results agreed with those of Pieper
(1999),
19 who showed that the vasorelaxation derived from
the endothelium increased on the first day after the applica-
tion of STZ in STZ-induced diabetic rats. This event was
followed by a reversal phase (one-two weeks), in which
vasorelaxation was normal, and a delayed phase (eight
weeks), during which the vasorelaxation became engaged.
Intravital microscopy, which has been extensively used
in microcirculation studies, allows in vivo measurements of
vascular permeability to various compounds.
6 The present
study demonstrated the occurrence of changes in micro-
vascular leakage within 2 min after histamine application
in diabetic hamsters. Nevertheless, the peak of the
response usually occurred 3 to 5 min after histamine
application and dissipated within 10 or 20 min. Histamine
Figure 2 - Changes of vimentin expression in arterioles (A-C) and venules (D-F) by immunohistochemical staining (brown color) (light
microscopy, 1,000X). a. The control group only showed a few vimentin-immunoreactive endothelial cells (arrow). b. The diabetic group
(6 days) showed positively-stained endothelial (arrow) and smooth muscle cells. c. The diabetic group (15 days) showed vimentin-
immunoreactive endothelial (arrow) and smooth muscle cells. d. The control group with few endothelial cells immunoreactive for
vimentin (arrowhead). e. The diabetic group (6 days) with a moderate amount of vimentin expression in the intimal and media layers.
f. The diabetic group (15 days) with a moderate amount of vimentin expression in the intimal and media layers. The scale bar=10 mm.
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1965binding to cell-surface receptors triggers subtle or rapid
changes in the contractility of endothelial cells that
depends on the cytoskeletal organization and cellular
adhesion. Therefore, we can suggest that hyperglycemia
influences vascular function at 6 and 15 days of diabetes
development and that this change may be associated with
subtle changes in the expression and distribution of
endothelial cell cytoskeleton components. No significant
changes were observed after 5 min of histamine applica-
tion between the two diabetes groups and the controls.
These data agreed with the results of Llorach and co-
workers (1976),
20 which did not show alterations in one-
two-week diabetic animal models.
Many reports have been published about functional and
morphological alterations that occur during the early stage of
diabetic disease in multiple animal models. In the present
Figure 3 - Changes of laminin expression in arterioles (A-C) and venules (D-F) by immunohistochemical staining (light microscopy,
1000X). a. The intimal layers of the hamsters in the control group were immunoreactive for laminin. b and c. All layers showed positive
laminin staining for both diabetic groups. d. The control group showed a poorly labeled intimal layer. e. The diabetic group (6 days)
with all layers staining positive. f. The diabetic group (15 days) with all layers staining positive. The scale bar=10 mm.
Table 2 - Distribution of actin, talin, a-SMA, vimentin, laminin, and type-IV collagen immunohistochemistry scores in
age-matched control and 6- and 15-day diabetic hamsters.
Antibodies Control 6 days of diabetes 15 days of diabetes
Arteriole Venule Arteriole Venule Arteriole Venule
Actin + + ++ + + +
Talin + + +++ + + +
a-SMA ++ + ++ +++ ++ +
Vimentin + + ++ ++ ++ ++
Laminin ++ + +++ ++ +++ ++
Type-IV collagen ++ ++ ++ ++ ++ ++
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1966study, no significant changes were observed in morpho-
metric or stereological measurements, in wall thickening or
microvessellumendiameters,inthedensityofthevesselsper
cheek pouch area (QA) or in volume density (Vv) during the
early stage of disease development. Morphological changes
require theaccumulation of ECMproteins glycated byAGEs
9
and are associated with basement membrane thickening.
14 In
part, this thickening may occur when cells synthesize
increased amounts of collagen IV.
21 The expression of type-
IV collagen, however, did not change in cheek pouch
microvessels, which may have resulted from a compensatory
mechanism to hyperglycemia in vascular cells that promoted
a change in the metabolism of type-IV collagen and increased
its turnover. An increase in the turnover of type-IV collagen
would avoid accumulation of type-IV collagen and result in a
thickening of the basement membrane.
There is some clinical and experimental evidence of
augmented blood flow at the early stage of diabetes.
22 Small
arteries have the most important influence on local blood
flow and are subjected to chemical and neurohormonal
influences as well as the continuous effect of mechanical
factors generated by the blood stream.
8 The endothelium
responds to mechanical stresses through mechanotransduc-
tion to regulate the vasomotion and function of the vascular
wall. Focal adhesions, which significantly contribute to
endothelial cell tethering, mediate the attachment of the
actin cytoskeleton to the ECM through a cytoplasmic
protein complex (i.e., the focal adhesion plaque).
23 Blood
vessel endothelial cells produce focal adhesion molecules,
including focal adhesion kinase, vinculin, talin, and cytos-
keletal b-actin.
In arterioles, we found that several proteins involved in
focal adhesion, such as actin, talin, vimentin, and laminin,
were increased in the DM6 group; however, the immuno-
labels for actin and talin in arterioles were decreased in the
DM15 hamsters.
Talin is part of the cytoskeletal protein complex that binds
the cytoplasmic tail of integrins to the b-actin cytoskeleton
in focal adhesions and is essential for focal adhesion
function.
24 Talin is essential for integrin activation, and it
is the initial weak link between integrins and the actin
cytoskeleton.
25
Talin,
26 actin and tubulin readily undergo nonenzymatic
glycosylation.
27 Loufrani and Henrion (2008)
28 reported that
AGEs promote an initial depolymerization of actin filaments
(actin F) and a subsequent decrease in actin G expression,
which corresponds with a reduction in actin microfilaments
and the disruption of cell-cell and cell-matrix junctions. In
our study, we used a single antibody to immunolabel both
forms of actin; this method could explain the increased
expression of actin at 6 days after the onset of diabetes. Talin
and actin are key proteins in focal adhesion and represent a
mechanical interaction between the cell and the ECM. The
force of contraction of the cell is related to focal adhesion.
29
Chronic hyperglycemia produces a nonenzymatic glycation
of talin and actin, which may contribute to reduced steady-
state adhesion strength and mechanosensing responses. In
addition, hyperglycemia can also promote further changes
in vascular permeability.
Diabetic hamsters presented increased labeling for lami-
nin in both vessel types. Because laminin is the primary
determinant of basement membrane assembly,
30 increased
laminin expression may suggest a structural remodeling of
vessel basement membranes.
We also found that vimentin was concomitantly
increased with laminin expression in blood vessels. All
three major cytoskeletal networks have been shown to
adapt their structures by elongating their cell shapes and
reorienting parallel to the flow direction.
31 Intermediate
filament cables, which are initially not under tension,
contribute to cell stiffness during large shear deformations.
This strain-hardening behavior in the intermediate cytos-
keleton filament likely prevents the excessive deformation
of the cell at finite strains that would otherwise rupture the
actin cytoskeleton.
32 Intermediate filaments may also
indirectly interact with focal adhesion sites. Indeed,
vimentin intermediate filaments are anchored to a6b4-
integrins in microvascular endothelial cells by plectin.
Because a6b4 binds to laminin, these interactions are
consistent with the hypothesis that intermediate filaments
are recruited to provide mechanical stability during
physiological adaptation of the microfilament network to
hemodynamic shear stress.
31 Thus, the increased expres-
sion of vimentin is associated with a proliferative pheno-
type, possibly due to hyperglycemia.
33 Antibodies against
laminin and vimentin inhibit branching morphogenesis in
vitro. Therefore, this adhesion structure may play a role in
angiogenesis.
34 Like the endothelial cell cytoskeleton,
smooth muscle cells are important in maintaining endothe-
lial structural integrity and in regulating endothelial
repair.
33
The expression of a-SMA in venules was enhanced in the
DM6 hamsters, and increased expression of a-SMA has
been shown to result in increased contractile force genera-
tion.
35 In addition, increased expression of a-SMA has been
shown to be associated with vessel stability.
32 The primary
function of smooth muscle cells (SMC) is the maintenance
of blood flow and pressure through their contractility, and
a-SMA is necessary for SMC and pericytes to interact with
endothelial cells to form a fully functional blood–tissue
barrier.
35
Our results suggest that changes related to cell-matrix
interactions occur in response to a new metabolic condition
(6 days of a diabetic state). These changes may contribute to
pathological remodeling of the microvessels and persist for
at least 15 days after the induction of diabetes.
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